Strengthening enrollment in an ASCVD clinical study
Targeted patient recruitment transforms an underperforming cardiovascular study into an enrollment success.
A struggling atherosclerotic cardiovascular disease (ASCVD) clinical study regained recruitment momentum through a focused, data-driven patient engagement strategy. By combining pre-consented patient registry data, localized digital outreach and specialized recruitment partners, the PPD™ clinical research business of Thermo Fisher Scientific built a stronger pipeline of qualified participants.
The approach resulted in 122 patients screened and 53 enrollments in just four months and ultimately helping the study complete enrollment eight weeks ahead of schedule.
Complete the form below to access the case study.